Nobuyoshi Maeji - Anteo Diagnostics Insider

ADO -- Australia Stock  

AUD 0.019  0.001  5.56%

Chief Scientific Officer
Dr. Nobuyoshi Joe Maeji, Ph.D., is Founder, Chief Scientific Officer of Anteo Diagnostics Limited. Dr. Joe Maeji is the founder of BioLayer. Prior to forming Bio Layer, Dr. Maeji held the position of Head of Research for Mimotopes Pty Ltd and Sr. Director for Small Molecule Drug Discovery for Chiron. At Mimotopes Pty Ltd., he directed RD, production as well as commercialization of products and technologies during the growth of this company
  Executive Since 2009  Ph.D    
61 7 3219 0085
Maeji holds a Ph.D. in Polymer Engineering from the Tokyo Institute of Technology.

Management Efficiency

The company has return on total asset (ROA) of (9.06) % which means that it has lost $9.06 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (61.43) % meaning that it generated substantial loss on money invested by shareholders.

Similar Executives

Showing few of many executives


Alan CarpenterWesfarmers Limited
Carolyn McCannWestpac Banking Corporation
David LindbergWestpac Banking Corporation
Andrew CuthbertsonCSL Limited
Adrian WentAustralia and New Zealand Banki
Lisa TobinTransurban Group
Paul MeadowsWesfarmers Limited
David OvingtonRio Tinto Limited
Bold BaatarRio Tinto Limited
Gerard FlorianAustralia and New Zealand Banki
Kate GriffithsBHP Billiton Limited
Margaret TaylorBHP Billiton Limited
Clare McManusCommonwealth Bank of Australia
Andrew BowdenWestpac Banking Corporation
Melanie LaingCommonwealth Bank of Australia
Julie GalliganTransurban Group
Alfredo BarriosRio Tinto Limited
Alan DaviesRio Tinto Limited
Debra ValentineRio Tinto Limited
David WhiteingCommonwealth Bank of Australia
Michael LiarakosAustralia and New Zealand Banki

Entity Summary

Anteo Diagnostics Limited engages in developing, commercializing, manufacturing, and distributing products for the life sciences, clinical diagnostics, and bioseparations markets. Anteo Diagnostics Limited is based in Eight Mile Plains, Australia. Anteo Diagnostics is traded on Australian Securities Exchange in Australia.Anteo Diagnostics Limited (ADO) is traded on Australian Securities Exchange in Australia. It is located in 4/26 Brandl Street and employs 99 people.

Anteo Diagnostics Limited Leadership Team

Nobuyoshi Maeji, Executive, Ph.D
Alan Studley, Director, CPA
John Hamilton, Chairman, Ph.D
Mark Bouris, Chairman
Peter HardingSmith, CFO
Matthew Sanderson, Director
John Hurrell, Director, Ph.D
Stefan Enderling, CEO, Ph.D
Geoffrey Cumming, CEO
Tamara Mills, COO
Julien McInally, Executive, CPA
Shane Hartwig, Executive
Nevin Abernethy, Executive
Richard Martin, Director
Jef Vangenechten, CEO, Ph.D
Rolf Sickman, Director
Sandra Andersen, Director, CPA

Stock Performance Indicators

Did you try this?

Run Portfolio Diagnostics Now

Portfolio Diagnostics

Use generated alerts and portfolio events aggregator to diagnose current holdings
All  Next Launch Portfolio Diagnostics

Pair Correlation

Equities Pair Trading Analysis
Correlation analysis and pair trading evaluation for Anteo Diagnostics and BHP Billiton Limited. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try Volatility Analysis module to get historical volatility and risk analysis based on latest market data.